Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wassmann

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Physiology|November 24, 1999
AT(1) receptor regulation in salt-sensitive hypertensionK Strehlow, G Nickenig, J Roeling, et al.
Circulation|October 12, 2000
Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cellsG Nickenig, K Strehlow, S Wassmann, et al.
British Journal of Pharmacology|October 13, 2000
Negative feedback regulation of reactive oxygen species on AT1 receptor gene expressionG Nickenig, K Strehlow, A T Bäumer, et al.
Molecular Pharmacology|February 17, 2001
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPaseS Wassmann, U Laufs, A T Bäumer, et al.
British Journal of Pharmacology|October 6, 2001
Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifeneA T Bäumer, S Wassmann, K Ahlbory, et al.
Circulation|February 7, 2001
Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive ratsS Wassmann, A T Bäumer, K Strehlow, et al.
Hypertension (Dallas, Tex. : 1979)|June 16, 2001
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen speciesS Wassmann, U Laufs, A T Bäumer, et al.
Journal of Cardiovascular Pharmacology|December 1, 2007
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery diseaseR M A van de Wal, P van der Harst, L J Wagenaar, et al.
European Heart Journal|February 22, 2013
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapyStefan Agewall, M Cattaneo, J P Collet, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Physiology|November 24, 1999
AT(1) receptor regulation in salt-sensitive hypertensionK Strehlow, G Nickenig, J Roeling, et al.
Circulation|October 12, 2000
Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cellsG Nickenig, K Strehlow, S Wassmann, et al.
British Journal of Pharmacology|October 13, 2000
Negative feedback regulation of reactive oxygen species on AT1 receptor gene expressionG Nickenig, K Strehlow, A T Bäumer, et al.
Molecular Pharmacology|February 17, 2001
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPaseS Wassmann, U Laufs, A T Bäumer, et al.
British Journal of Pharmacology|October 6, 2001
Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifeneA T Bäumer, S Wassmann, K Ahlbory, et al.
Circulation|February 7, 2001
Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive ratsS Wassmann, A T Bäumer, K Strehlow, et al.
Hypertension (Dallas, Tex. : 1979)|June 16, 2001
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen speciesS Wassmann, U Laufs, A T Bäumer, et al.
Journal of Cardiovascular Pharmacology|December 1, 2007
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery diseaseR M A van de Wal, P van der Harst, L J Wagenaar, et al.
European Heart Journal|February 22, 2013
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapyStefan Agewall, M Cattaneo, J P Collet, et al.
Pageof 2